379 related articles for article (PubMed ID: 22358181)
1. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs.
Harada K; Sato Y; Ikeda H; Maylee H; Igarashi S; Okamura A; Masuda S; Nakanuma Y
Virchows Arch; 2012 Mar; 460(3):281-9. PubMed ID: 22358181
[TBL] [Abstract][Full Text] [Related]
2. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
3. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
[TBL] [Abstract][Full Text] [Related]
4. Hepatobiliary cancers, version 2.2014.
Benson AB; D'Angelica MI; Abrams TA; Are C; Bloomston PM; Chang DT; Clary BM; Covey AM; Ensminger WD; Iyer R; Kelley RK; Linehan D; Malafa MP; Meranze SG; Park JO; Pawlik T; Posey JA; Scaife C; Schefter T; Sigurdson ER; Tian GG; Vauthey JN; Venook AP; Yen Y; Zhu AX; Hoffmann KG; McMillian NR; Sundar H
J Natl Compr Canc Netw; 2014 Aug; 12(8):1152-82. PubMed ID: 25099447
[TBL] [Abstract][Full Text] [Related]
5. Notch1-Hes1 signalling axis in the tumourigenesis of biliary neuroendocrine tumours.
Harada K; Sato Y; Ikeda H; Hsu M; Igarashi S; Nakanuma Y
J Clin Pathol; 2013 May; 66(5):386-91. PubMed ID: 23423517
[TBL] [Abstract][Full Text] [Related]
6. [Tumor grading of the hepatobiliary system].
Jütte H; Tannapfel A
Pathologe; 2016 Jul; 37(4):299-303. PubMed ID: 27342594
[TBL] [Abstract][Full Text] [Related]
7. Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms.
Mounajjed T; Zhang L; Wu TT
Hum Pathol; 2013 Apr; 44(4):542-50. PubMed ID: 23079207
[TBL] [Abstract][Full Text] [Related]
8. [Gallbladder and bile duct carcinoma. Biology and pathology].
Tannapfel A; Wittekind C
Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the anterior gradient protein-2 is a conserved feature during morphogenesis and carcinogenesis of the biliary tree.
Lepreux S; Bioulac-Sage P; Chevet E
Liver Int; 2011 Mar; 31(3):322-8. PubMed ID: 21281432
[TBL] [Abstract][Full Text] [Related]
10. Primary Biliary Mixed Adenoneuroendocrine Carcinoma (MANEC): A Short Review.
Acosta AM; Wiley EL
Arch Pathol Lab Med; 2016 Oct; 140(10):1157-62. PubMed ID: 27684986
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver.
Shimonishi T; Miyazaki K; Nakanuma Y
Histopathology; 2000 Jul; 37(1):55-63. PubMed ID: 10931219
[TBL] [Abstract][Full Text] [Related]
12. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles.
Sasaki M; Nakanuma Y; Ho SB; Kim YS
Am J Clin Pathol; 1998 Mar; 109(3):302-8. PubMed ID: 9495202
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas.
Koh J; Nam SK; Kwak Y; Kim G; Kim KK; Lee BC; Ahn SH; Park DJ; Kim HH; Park KU; Kim WH; Lee HS
J Pathol; 2021 Jan; 253(1):94-105. PubMed ID: 32985687
[TBL] [Abstract][Full Text] [Related]
14. Primary Mixed Adenoneuroendocrine Carcinoma of the Gallbladder in a 55-Year-Old Female Patient: A Case Report and Review of the Literature.
Acosta AM; Hamedani FS; Kajdacsy-Balla A; Wiley EL
Int J Surg Pathol; 2015 Aug; 23(5):414-8. PubMed ID: 25838330
[TBL] [Abstract][Full Text] [Related]
15. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
[TBL] [Abstract][Full Text] [Related]
16. Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules.
Gandou C; Harada K; Sato Y; Igarashi S; Sasaki M; Ikeda H; Nakanuma Y
Hum Pathol; 2013 May; 44(5):811-21. PubMed ID: 23134772
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53 in adenocarcinoma of the gallbladder and bile ducts.
Washington K; Gottfried MR
Liver; 1996 Apr; 16(2):99-104. PubMed ID: 8740842
[TBL] [Abstract][Full Text] [Related]
19. Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: a case report and review of the literature.
Zheng SL; Yip VS; Pedica F; Prachalias A; Quaglia A
Diagn Pathol; 2015 Nov; 10():204. PubMed ID: 26589730
[TBL] [Abstract][Full Text] [Related]
20. Albumin In Situ Hybridization Can Be Positive in Adenocarcinomas and Other Tumors From Diverse Sites.
Nasir A; Lehrke HD; Mounajjed T; Said S; Zhang L; Yasir S; Shah SS; Chandan VS; Smyrk TC; Moreira RK; Boland Froemming JM; Herrera Hernandez LP; Wu TT; Graham RP
Am J Clin Pathol; 2019 Jul; 152(2):190-199. PubMed ID: 31107526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
